SLAM
DGX icon

Swiss Life Asset Management’s Quest Diagnostics DGX Stock Holding History

Swiss Life Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1M Buy
66,553
+13,687
+26% +$2.69M 0.06% 245
2026
Q1 		$10.4M Buy
52,866
+9,528
+22% +$1.85M 0.05% 266
2025
Q4 		$7.52M Buy
43,338
+24,722
+133% +$4.5M 0.04% 327
2025
Q3 		$3.55M Sell
18,616
-1,598
-8% -$284K 0.02% 472
2025
Q2 		$3.63M Sell
20,214
-19,664
-49% -$3.42M 0.02% 446
2025
Q1 		$6.75M Sell
39,878
-14,742
-27% -$2.42M 0.05% 291
2024
Q4 		$8.24M Buy
54,620
+7,674
+16% +$1.19M 0.06% 226
2024
Q3 		$7.29M Buy
46,946
+27,125
+137% +$4.05M 0.08% 209
2024
Q2 		$2.71M Buy
19,821
+16,838
+564% +$2.31M 0.03% 338
2024
Q1 		$397K Sell
2,983
-13,771
-82% -$1.79M 0.01% 473
2023
Q4 		$2.31M Sell
16,754
-29,088
-63% -$3.82M 0.03% 421
2023
Q3 		$5.59M Buy
45,842
+13,338
+41% +$1.78M 0.09% 268
2023
Q2 		$4.57M Sell
32,504
-48,103
-60% -$6.63M 0.07% 329
2023
Q1 		$11.4M Buy
80,607
+1,441
+2% +$206K 0.17% 146
2022
Q4 		$12.4M Buy
79,166
+4,901
+7% +$704K 0.21% 126
2022
Q3 		$9.11M Buy
74,265
+2,431
+3% +$320K 0.16% 159
2022
Q2 		$9.56M Buy
71,834
+18,436
+35% +$2.51M 0.15% 166
2022
Q1 		$7.31M Sell
53,398
-2,020
-4% -$282K 0.1% 219
2021
Q4 		$9.59M Buy
55,418
+43,646
+371% +$6.64M 0.12% 197
2021
Q3 		$1.71M Buy
11,772
+8,872
+306% +$1.3M 0.02% 430
2021
Q2 		$303K Sell
2,900
-58,038
-95% -$7.6M ﹤0.01% 517
2021
Q1 		$7.82M Buy
60,938
+6,065
+11% +$747K 0.11% 222
2020
Q4 		$6.54M Sell
54,873
-5,091
-8% -$621K 0.1% 242
2020
Q3 		$6.87M Sell
59,964
-10,253
-15% -$1.21M 0.1% 159
2020
Q2 		$8M Sell
70,217
-2,386
-3% -$253K 0.13% 134
2020
Q1 		$5.83M Buy
72,603
+11,240
+18% +$1.16M 0.11% 154
2019
Q4 		$6.55M Sell
61,363
-27,152
-31% -$2.83M 0.12% 148
2019
Q3 		$9.47M Buy
88,515
+86,443
+4,172% +$8.87M 0.12% 132
2019
Q2 		$210K Buy
+2,072
New +$199K ﹤0.01% 535
2018
Q4 		– Sell
-6,855
Closed -$740K – 259
2018
Q3 		$740K Sell
6,855
-18,529
-73% -$2.03M 0.01% 414
2018
Q2 		$2.79M Buy
+25,384
New +$2.64M 0.04% 237
2017
Q4 		– Sell
-41,810
Closed -$3.91M – 489
2017
Q3 		$3.91M Buy
41,810
+12,529
+43% +$1.33M 0.1% 135
2017
Q2 		$3.25M Sell
29,281
-25,004
-46% -$2.64M 0.08% 147
2017
Q1 		$5.33M Buy
54,285
+41,529
+326% +$3.96M 0.14% 109
2016
Q4 		$1.17M Sell
12,756
-21,533
-63% -$1.86M 0.04% 228
2016
Q3 		$2.9M Buy
34,289
+13,640
+66% +$1.15M 0.1% 124
2016
Q2 		$1.68M Buy
20,649
+13,078
+173% +$996K 0.07% 143
2016
Q1 		$541K Sell
7,571
-9,749
-56% -$654K 0.02% 260
2015
Q4 		$1.23M Buy
17,320
+3,322
+24% +$223K 0.05% 134
2015
Q3 		$860K Sell
13,998
-2,828
-17% -$198K 0.04% 153
2015
Q2 		$1.22M Sell
16,826
-17,538
-51% -$1.29M 0.04% 131
2015
Q1 		$2.64M Buy
+34,364
New +$2.46M 0.11% 106

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Swiss Life Asset Management's DGX Position: Q2 2026 in Review

Swiss Life Asset Management increased its Quest Diagnostics (DGX) stake by 26% in Q2 2026, buying an estimated $2.69M and bringing the position to 66,553 shares worth $14.1M. The position accounts for 0.06% of the portfolio, ranked #245.

Swiss Life Asset Management first reported a position in DGX in Q1 2015 and has held it in 42 quarters since. 872 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Swiss Life Asset Management held 66,553 shares of Quest Diagnostics worth $14.1M as of Q2 2026.
  • Swiss Life Asset Management bought 13,687 Quest Diagnostics shares in Q2 2026, an estimated $2.69M.
  • Quest Diagnostics made up 0.06% of Swiss Life Asset Management's portfolio in Q2 2026, its #245 holding.
  • Swiss Life Asset Management first reported a position in Quest Diagnostics in Q1 2015 and has held it in 42 quarters since.
  • 872 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.